Program
Below please find the outline of the program. Detailed scientific program, including abstract-driven presentations, is available at the right of the screen.
| Wednesday 23 March 2011 |
| 11:00h |
Opening of the Workshop |
|
Introduction |
|
| 11:15 - 12:00h | Keynote lecture: Viral attack and cellular defense: The role of cellular restrictions in the biology of primate lentiviruses Invited speaker: Mario Stevenson, PhD, University of Miami, USA |
| Session 1 |
Resistance to the Integrase HIV Inhibitors |
| 12:00 - 12:50h |
Abstract presentations |
| 12:50 - 14:00h |
Lunch |
| Session 2 |
Resistance to the RT and Pro HIV Inhibitors |
| 14:00 - 15:00h |
Abstract presentations |
| 15:00 - 15:30h |
Clinical case: Dilemmas in HIV care |
| 15:30 - 16:30h |
Coffee break & poster viewing session I |
| Session 3 | Molecular epidemiology of HIV Infection |
| 16:30 - 17:45h |
Abstract presentations |
| 17:45h |
Welcome drinks & poster viewing session II |
| Thursday 24 March 2011 | |
| Session 4 | Novel strategies in Hepatitis C therapy |
| 8:00 - 8:30h |
Drug Development for viral hepatitis |
| 8:30 - 9:00h |
Clinical considerations in HCV management |
| 9:00 - 9:40h |
Abstract presentations |
| 9:50 - 10:20h |
HIV - HCV co-infections |
| 10:20 - 10:50h |
Coffee break |
| Session 5 | Novel strategies in Hepatitis B therapy |
| 10:50 - 11:20h |
Basic concepts of HBV therapy |
| 11:20 - 11:50h | Clinical Considerations in HBV management Invited speaker: Massimo Levrero, MD, University of Rome "La Sapienza", Italy |
| 12:00 - 12:20 | Abstract presentations |
| 12:20 - 12:50 | Clinical Considerations in HBV management Invited speaker: Massimo Puoti, MD, Niguarda Ca'Granda Hospital, Italy |
| 13:00 - 14:00h |
Lunch |
| Session 6 |
Clinical case presentations |
| 14:00 - 14:20h |
Clinical case: Dilemmas in HCV care |
| 14:20 - 14:40h |
Clinical case: Dilemmas in HBV care |
| 14:40 - 15:10h | Clinical case: The co-infected patient Presenter: Anders Sönnerborg, MD, PhD, Karolinska Institute, Sweden |
| Session 7 |
Analysis of Co-receptor usage |
| 15:10 - 15:50h | Abstract Presentations |
| 15:50 - 16:20h |
Coffee break |
| 16:20 - 17:10h |
Abstract Presentations |
| 17:20 - 17:45h | Introduction European Society for Antiviral Resistance EU guidelines on Clinical Management of HIV-1 Tropism testing |
| 17:14 - 18:00h | Introduction HepVir project group |
| 18:00h | Poster viewing session III |
| 19:30h | Workshop dinner |
| Friday 25 March 2011 |
| Session 8 | Evolving treatment strategies in HIV care |
| 08:00 - 8:30h |
Shifting Paradigms in the management of HIV infection |
| 8:30 - 9:20h |
Abstract Presentations |
| 9:20 - 11:00h |
Round table discussion: How do we select an optimal antiretroviral regimen in clinical practice? |
| 10:30 - 11:00h |
Coffee break |
| Session 9 |
Novel diagnostic technologies & interpretation approaches |
| 11:00 - 11:30h |
Applying bioinformatics to clinical practice: what will the future bring? |
| 11:30 - 11:50h | Abstract Presentations |
| 12:00 - 13:00h | Round table discussion: the future of HIV patient care What is the role of virological monitoring in 2011 Point of care diagnostics Challenge in treatment monitoring in Eastern Europe Speaker: Stephan Dressler, MD, PhD, EATG, Germany |
| 13:00h |
Closing |
Please find below the confirmed speakers for the 2011 workshop:
CONFIRMED INVITED SPEAKERS
-
Thomas Lengauer: Future of Bioinformatics in Interpretation Applications
Prof. Dr. Dr. Thomas Lengauer is Director at the Max Planck Institute for Informatics and an honorary professor of Informatics at Saarland University in Saarbrücken, Germany and of the University of Bonn, Germany.
...
-
Massimo Levrero: Clinical Considerations in HBV management
Picture and bio will follow soon
-
Johan Neyts: Drug Development for Viral Hepatitis
Johan Neyts, MD, PhD, is full professor of virology at the University of Leuven, Belgium. His research is focused on the development of novel antiviral strategies against a number of viruses including picornaviruses, flaviviruses and HCV.
...
-
Jean Michel Pawlotsky: Clinical Considerations in HCV Management
Jean-Michel Pawlotsky, MD, PhD is Professor of Medicine at the University of Paris-Est. He is the Director of the National Reference Center for Viral Hepatitis B, C and Delta and of the Department of Virology at the Henri Mondor University Hospital in Créteil, France, and Director of the Department of Molecular Virology and Immunology at the "Institut Mondor de Recherche Biomédicale" (INSERM U955). ...
-
Massimo Puoti: HIV - HBV Co-infections
Bio will follow soon
-
Jonathan Schapiro: Shifting Paradigms in the Management of HIV Infection
Jonathan M Schapiro, MD has devoted his career to HIV clinical care, research and education since completing his Fellowship in Infectious Diseases and Geographic Medicine at the Stanford University School of Medicine Center For AIDS Research, Stanford CA. Dr. Schapiro Graduated from the Ben Gurion University School of Medicine and completed his Medicine Residency at the Rabin Medical Center in Israel. ...
-
Vincent Soriano: HIV - HCV Co-infections
Vincent Soriano, MD, PhD, received his medical degree at the Autonomous University of Barcelona, when he subsequently did his specialty in Internal Medicine. After a post-doc stage at the FDA (Bethesda, MD, USA), he returned to Spain and joined the Department of Infectious Diseases at Hospital Carlos III in Madrid, where since 1999 he is the Assistant Director. ...
-
Mario Stevenson: Host Restriction Factors
Mario Stevenson, PhD, received his PhD from the University of Strathclyde in Glasgow Scotland in 1984. He performed postdoctoral studies at the University of Nebraska Medical Center and was a professor at that institution from 1993-1995. He conducted a research sabbatical at National Institute for Medical Research in London in 1990.
...
-
Fabien Zoulim: Basic Concepts of HBV Therapy
Fabien Zoulim, MD, PhD, obtained his M.D. in Gastroenterology and Hepatology in Lyon Medical School in 1991. He has also obtained a PhD in Molecular and Cellular Biology and was trained as a post-doctoral researcher at Fox Chase Cancer Center in Philadelphia. He has been a Professor of Medicine at Lyon I University since 1997. He is currently Medical Director of the Liver Department at the Hospices Civils de Lyon, and Scientific Director of the INSERM Unit 871 where he is leading the team on ‘Antiviral therapy of viral hepatitis'. ...
Round table discussion:
-
Ricardo Camacho: The role of generic antiretroviral drugs
Ricardo Camacho, MD, graduated in Medicine in Lisbon Medical School, Universidade de Lisboa. With a specialization in Transfusion Medicine, and several years of clinical practice, he becomes in 1994 the head of Virology Laboratory in Hospital Egas Moniz, in Lisbon, later one of the Portuguese AIDS reference laboratories. ...
Round table discussion: The future of patient care
-
Stephan Dressler: Challenges in treatment monitoring in Eastern Europe
Stephan Dressler, MD, PhD, received his Doctor of Philosophy and his Doctor of Medicine at Freie Universitaet Berlin, Germany. After working as editor for scientific publishers, he joined the National AIDS Centre at the Federal Health Office at Berlin in 1990. In 1992, he became a co-founder of the European AIDS Treatment Group (EATG). Since 1994, he is working as a freelance author, providing patient information on HIV, hepatitis and STIs, publishing medicial dictionaries, and web-based educational materials. ...